BIOMAT Database Logo BIOMAT Database Logo

Response to saralasin and angiotensin's role in essential and renal hypertension. 1979

N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy
Diuretic therapy and response of essential hypertension to saralasin.
August 1977, Annals of internal medicine,
N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy
Pressor response to saralasin reversed by phentolamine in essential hypertension.
June 1978, The New England journal of medicine,
N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy
Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
August 1977, Annals of internal medicine,
N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy
Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
April 1982, The American journal of cardiology,
N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy
[Saralasin test in the differential diagnosis of essential and renal hypertension].
February 1986, Zeitschrift fur Urologie und Nephrologie,
N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy
Saralasin infusion in renovascular and essential hypertension.
January 1980, The Netherlands journal of medicine,
N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy
[Saralasin for renovascular or essential hypertension (author's transl)].
November 1978, Deutsche medizinische Wochenschrift (1946),
N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy
Negative saralasin response in correctable renovascular hypertension.
September 1978, The Journal of pediatrics,
N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy
[Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
September 1978, Klinische Wochenschrift,
N K Hollenberg, and G H Williams, and D F Adams, and T Moore, and C Brown, and L J Borucki, and F Leung, and S Bavli, and H S Solomon, and D Passan, and R Dluhy
Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
May 1980, Circulation,
Copied contents to your clipboard!